Johan Erik Häggblad
Chief Tech/Sci/R&D Officer at CALLIDITAS THERAPEUTICS AB
Network origin in Johan Erik Häggblad first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
81
| Extinct | Pharmaceuticals: Major | 81 |
| Public Company | Pharmaceuticals: Major | 36 | |
Epicyt Pharma AB
 Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
| Public Company | Pharmaceuticals: Major | 3 | |
Nefecon AB
 Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Busulipo AB
 Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden.
1
| Private Company | Pharmaceuticals: Major | 1 |
Pharmalink Nordic AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Johan Erik Häggblad via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Human Resources Officer Sales & Marketing Compliance Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| MONSANTO | Wholesale Distributors | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Public Communications Contact General Counsel Chief Administrative Officer Human Resources Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal General Counsel Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Masters Business Admin Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer Chairman Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Chief Executive Officer Human Resources Officer | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| WEIFA ASA | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Public Communications Contact | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director/Board Member President Chief Tech/Sci/R&D Officer | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| MEDCAP AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal President Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Public Communications Contact Director/Board Member Corporate Officer/Principal | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| Georgia State University | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Public Communications Contact | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Chairman Director/Board Member | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member President | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer President | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chairman | |
| DUN & BRADSTREET CORP | Data Processing Services | Director/Board Member Director of Finance/CFO |
Statistics
International
| United States | 30 |
| Sweden | 14 |
| Canada | 3 |
| Norway | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Distribution Services | 2 |
| Process Industries | 2 |
Operational
| Director/Board Member | 568 |
| Corporate Officer/Principal | 250 |
| Independent Dir/Board Member | 181 |
| Chairman | 164 |
| Chief Executive Officer | 104 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Lennart Eklund | 57 |
| Carola Elisabet Lemne | 47 |
| Bengt Åke Julander | 36 |
| Stig Lennart Hansson | 32 |
| Elmar Schnee | 31 |
| Michael Friedman | 30 |
| Anders Paul Wiklund | 29 |
| Mark Corrigan | 29 |
| Fred Hassan | 29 |
| Joseph Papa | 28 |
| Paul Edick | 27 |
| Håkan Åström | 26 |
| Thomas Paul Koestler | 26 |
| Renée Aguiar-Lucander | 26 |
| Charles Rowland | 25 |
- Stock Market
- Insiders
- Johan Erik Häggblad
- Company connections
